Workflow
Yunnan Germanium(002428)
icon
Search documents
云南临沧鑫圆锗业股份有限公司第八届董事会第三十二次会议决议公告
Core Viewpoint - The company, Yunnan Lincang Xin Yuan Germanium Co., Ltd., has approved the establishment of a holding subsidiary, Yunnan Germanium Biotechnology Co., Ltd., through a joint investment of 10 million RMB with Kunming Haliwa Enterprise Management Partnership, focusing on the development of daily chemical products and other applications related to organic germanium [5][20]. Group 1: Investment Overview - The board of directors approved the investment to establish a holding subsidiary with a total capital of 10 million RMB, where the company will contribute 7 million RMB and Kunming Haliwa will contribute 3 million RMB [5][20]. - The new subsidiary will primarily engage in the development of daily chemical products centered around organic germanium [5][20]. Group 2: Subsidiary Details - The proposed subsidiary, Yunnan Germanium Biotechnology Co., Ltd., will have a registered capital of 10 million RMB and will be located in the Kunming High-tech Industrial Development Zone [8][9]. - The business scope of the subsidiary includes research and application of cell technology, production and sales of daily chemical products, and health consulting services, among others [8][9]. Group 3: Investment Purpose and Impact - The investment aims to cultivate a business segment with sustainable growth potential, extending the company's main business downstream and enhancing its industrial chain layout [20]. - The funding for this investment will come entirely from the company's own funds, ensuring that normal operations and financial stability are maintained [20].
A股公告精选 | 摩尔线程(688795.SH)拟使用不超过75亿元闲置募集资金进行现金管理
智通财经网· 2025-12-12 12:09
Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]
云南锗业:拟设立控股子公司 从事有机锗相关业务
人民财讯12月12日电,云南锗业(002428)12月12日公告,公司拟与昆明哈傈佤企业管理合伙企业(有 限合伙)共同出资1000万元设立控股子公司云南锗业生物科技有限公司(暂定名,简称"云锗生物")。云锗 生物主要从事以有机锗为核心的日化产品及其他有机锗相关应用产品的开发业务。 ...
云南锗业:拟设立控股子公司云南锗业生物科技有限公司
Mei Ri Jing Ji Xin Wen· 2025-12-12 10:18
Group 1 - Yunnan Zhenye (SZ 002428) announced the establishment of a new subsidiary, Yunnan Zhenye Biotechnology Co., Ltd., with a total investment of 10 million yuan [1] - The new subsidiary will focus on the development of daily chemical products and other applications related to organic germanium [1] - As of the announcement, Yunnan Zhenye's market capitalization is 19 billion yuan [1]
云南锗业(002428) - 关于对外投资设立控股子公司的公告
2025-12-12 10:16
证券代码:002428 证券简称:云南锗业 公告编号:2025-067 云南临沧鑫圆锗业股份有限公司 关于对外投资设立控股子公司的公告 本公司及董事会全体成员保证公告内容真实、准确和完整,没有虚假记载、 误导性陈述或重大遗漏。 一、对外投资概述 注册地址:云南省昆明高新技术产业开发区马金铺街道办事处大营社区居委 会魁星街 666 号云南国家锗材料基地综合测试实验大楼 1 楼 101 室 企业类型:有限合伙企业 注册资本:300 万元 执行事务合伙人:杨军 成立日期:2025 年 12 月 3 日 2025 年 12 月 12 日,云南临沧鑫圆锗业股份有限公司(以下简称"公司" 或"本公司")第八届董事会第三十二次会议审议通过《关于对外投资设立控股 子公司的议案》,同意公司与昆明哈傈佤企业管理合伙企业(有限合伙)(以下 简称"昆明哈傈佤")共同出资 1,000 万元设立控股子公司云南锗业生物科技有 限公司(暂定名,以下简称"云锗生物")。云锗生物主要从事以有机锗为核心 的日化产品及其他有机锗相关应用产品的开发业务。 本次对外投资事项不构成关联交易,不构成《上市公司重大资产重组管理办 法》规定的重大资产重组,无需 ...
云南锗业(002428) - 第八届董事会第三十二次会议决议公告
2025-12-12 10:15
证券代码:002428 证券简称:云南锗业 公告编号:2025-066 云南临沧鑫圆锗业股份有限公司 第八届董事会第三十二次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整,没有虚假记载、 误导性陈述或重大遗漏。 云南临沧鑫圆锗业股份有限公司(以下简称"公司")第八届董事会第三十 二次会议通知于 2025 年 12 月 8 日以通讯方式发出,并于 2025 年 12 月 12 日以 通讯方式召开。会议应出席董事 7 名,实际出席董事 7 名。本次会议出席人数、 召开程序、议事内容均符合《公司法》和《公司章程》的规定。会议经表决形成 如下决议: 会议以 7 票同意,0 票反对,0 票弃权,通过《关于对外投资设立控股子公 司的议案》。 同意公司与昆明哈傈佤企业管理合伙企业(有限合伙)(以下简称"昆明哈 傈佤")共同出资 1,000 万元设立控股子公司云南锗业生物科技有限公司(暂定 名,以下简称"云锗生物"),其中:公司以货币资金形式认缴出资 700 万元, 昆明哈傈佤以货币资金形式认缴出资 300 万元。云锗生物主要从事以有机锗为核 心的日化产品及其他有机锗相关应用产品的开发业务。 详细内容请见公 ...
云南锗业拟控股设立云锗生物 开展有机锗相关业务
Zhi Tong Cai Jing· 2025-12-12 10:12
云南锗业(002428)(002428.SZ)公告,公司董事会审议通过《关于对外投资设立控股子公司的议 案》,同意公司与昆明哈傈佤企业管理合伙企业(有限合伙)(简称"昆明哈傈佤")共同出资1000万元设立 控股子公司云南锗业生物科技有限公司(暂定名,简称"云锗生物")。云锗生物主要从事以有机锗为核心 的日化产品及其他有机锗相关应用产品的开发业务。 ...
云南锗业:共同出资1000万元设立云南锗业生物科技有限公司
Xin Lang Cai Jing· 2025-12-12 10:11
云南锗业公告,公司与昆明哈傈佤企业管理合伙企业(有限合伙)共同出资1000万元设立控股子公司云 南锗业生物科技有限公司。其中,公司出资700万元,占股70%,昆明哈傈佤出资300万元,占股30%。 云锗生物主要从事以有机锗为核心的日化产品及其他有机锗相关应用产品的开发业务。 ...
云南锗业(002428.SZ):拟设立控股子公司云南锗业生物科技有限公司
Ge Long Hui A P P· 2025-12-12 10:11
格隆汇12月12日丨云南锗业(002428.SZ)公布,第八届董事会第三十二次会议审议通过《关于对外投资 设立控股子公司的议案》,同意公司与昆明哈傈佤企业管理合伙企业(有限合伙)(简称"昆明哈傈 佤")共同出资1,000万元设立控股子公司云南锗业生物科技有限公司(暂定名,简称"云锗生物")。云 锗生物主要从事以有机锗为核心的日化产品及其他有机锗相关应用产品的开发业务。 ...
云南锗业(002428.SZ)拟控股设立云锗生物 开展有机锗相关业务
智通财经网· 2025-12-12 10:09
智通财经APP讯,云南锗业(002428.SZ)公告,公司董事会审议通过《关于对外投资设立控股子公司的议 案》,同意公司与昆明哈傈佤企业管理合伙企业(有限合伙)(简称"昆明哈傈佤")共同出资 1000 万元设立 控股子公司云南锗业生物科技有限公司(暂定名,简称"云锗生物")。云锗生物主要从事以有机锗为核心 的日化产品及其他有机锗相关应用产品的开发业务。 ...